Australian researchers say access to a free medicated nasal spray which temporarily reverses the effects of opioid toxicity while waiting for an ambulance to arrive, will save lives and reduce opioid-related hospital admissions.
Scientists are using artificial intelligence and powerful computing to sculpt new molecules in an effort to treat disease.
Chulalongkorn University congratulates Associate Professor Dr. Rungpetch C. Sakulbumrungsil, former Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, on receiving the 2024 FAPA Ishidate Award in the field of Pharmacy Education. The award, presented by the Federation of Asian Pharmaceutical Associations (FAPA), honors pharmacists who have made significant contributions to the field. The award ceremony took place during the opening of the FAPA Congress 2024 on October 31, 2024, in Seoul, South Korea.
A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions such as irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD), which affect millions of people worldwide. The research results were recently published in the international edition of the renowned journal Angewandte Chemie.
Kedrion Biopharma Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the company's manufacturing facility in Bolognana, Italy, to produce RYPLAZIM®.
A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African tree that has been used in traditional healing in Cameroon to treat a variety of diseases and conditions including cancers and diabetes.
PharmassêtX Inc., a late-preclinical stage pharmaceutical development company, today announced that the US Patent and Trademark Office has acknowledged receipt of the Company's patent application entitled "CRYSTALLINE FORM OF EPIGALLOCATECHIN-3-GALLATE." PharmassêtX is developing the novel form of epigallocatechin gallate (EGCG) as a prescription drug for the treatment of inflammatory bowel disease (IBD).
The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive weeklong training program at the Institute.
Relief is coming for crime scene investigators and toxicologists who have struggled to accurately and swiftly identify drugs that have been seized by law enforcement and may be relied on as evidence at trial, thanks to a research partnership between West Virginia University and the U.S. Drug Enforcement Administration.
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.
Today, Tufts University announced that Loring Tu, a professor in the Department of Mathematics, has made a substantial gift to name the Science and Engineering Complex (SEC) in honor of his late grandfather, Tsungming Tu, who was a world-renowned doctor and expert on pharmacology, toxicology, and medical education. Going forward, the SEC will be known as the Tsungming Tu Complex (TTC).
The Federal Drug Administration is looking to remove the oral phenylephrine ingredient from over-the-counter medicines. ...
Nearly three dozen Binghamton University, State University of New York researchers have been honored for their work by a Stanford University study that looks at the impact of scientists worldwide. The recently released ranking has identified 33 current faculty who were among the top 2% of all researchers in the world in their fields in 2023.
Scientists have identified a molecule that appears to restore normal breathing in mice following a large dose of fentanyl.
Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world’s deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute Myelogenous Leukemia (AML) TeamLab.
Inscripta, Inc., a leading life science technology company helping to create the bioeconomy, has successfully completed scale-up runs and is moving into commercial manufacturing of an anti-aging skincare ingredient.
Scientists from Immanuel Kant Baltic Federal University showed that spraying of selenium stimulates the growth of garden sage – a plant, that is used in medicine for treatment of inflammations and diseases of gastrointestinal tract.
A research team has unveiled the unique chemical, microstructural, rheological, and flavor-related properties of four commercially available microalgal species—Arthrospira, Isochrysis, Nannochloropsis, and Tetraselmis.
With its emphasis on opioid overdose prevention, the first guideline for primary care providers from the American Academy of Pediatrics (AAP) on prescribing opioids for acute pain in children and adolescents extends beyond responsible pain management.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right